Chlamydial and Gonococcal Testing during Pregnancy in the United States
American Journal of Obstetrics and Gynecology, 05/04/2012Blatt AJ et al.
Many pregnant women are not tested for Chlamydia trachomatis and Neisseria gonorrhoeae despite recommendations to test. Follow–up testing to monitor the effectiveness of treatment is also not always performed.
Authors extracted laboratory results for 1,293,423 pregnant women tested over a three–year period.
During pregnancy, 59% (761,315/1,293,423) and 57% (730,796/1,293,423) women were tested at least once forC. trachomatis or for N. gonorrhoeae, respectively.
Of those women tested, 3.5% (26,437/761,315) and 0.6% (4,605/730,796) tested positive for chlamydial and gonococcal infection, respectively, at least once during pregnancy.
Of those women initially positive for the given infection, 78.3% (16,039/20,489) and 75.6% (2,610/3,435) were retested, of whom 6.0% (969/16,039) and 3.8% (100/2,610) were positive on their last prenatal test for C. trachomatis and N. gonorrhoeae, respectively.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.